Suppressing Lynx1 helps brain recovery after stroke in mice
Reducing Lynx1 levels can improve the effectiveness of rehabilitation during the chronic phase after a stroke.
Researchers found that suppressing Lynx1 reopens a window for effective rehabilitation after a stroke in mice. This suppression improves spontaneous motor recovery and helps rehabilitation work better during the chronic phase.
Scientists used a focal ischemic stroke mouse model to study why rehabilitation efficacy decreases during the transition from the subacute to the chronic phase. They identified Lynx1 as a negative regulator of post-stroke neural plasticity.
Lynx1 is an endogenous negative allosteric modulator of nicotinic acetylcholine receptors. Neural plasticity is a process that declines during the transition to the chronic phase. The molecular and cellular mechanisms regulating these changes remain unclear.
Lynx1 expression in layer 5 pyramidal neurons was transiently down-regulated and then returned to normal levels in the peri-infarct area. Suppressing Lynx1 promoted synaptic clustering and increased dendritic spine turnover in that area.
Dendritic spine dynamics in the peri-infarct area may be a key determinant of rehabilitation responsiveness. Researchers developed a Lynx1-targeting antisense oligonucleotide to enhance rehabilitation efficacy during the chronic phase.
Lynx1 may represent a promising therapeutic target for augmenting dendritic plasticity after stroke.
Key facts
- Lynx1 suppression promotes synaptic clustering and increased dendritic spine turnover.
- A Lynx1-targeting antisense oligonucleotide enhanced rehabilitation efficacy in the chronic phase.
- Lynx1 acts as a negative regulator of post-stroke neural plasticity.